U.S. flag

An official website of the United States government

NM_004004.6(GJB2):c.551G>A (p.Arg184Gln) AND Nonsyndromic genetic hearing loss

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Aug 24, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002281716.10

Allele description [Variation Report for NM_004004.6(GJB2):c.551G>A (p.Arg184Gln)]

NM_004004.6(GJB2):c.551G>A (p.Arg184Gln)

Gene:
GJB2:gap junction protein beta 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q12.11
Genomic location:
Preferred name:
NM_004004.6(GJB2):c.551G>A (p.Arg184Gln)
HGVS:
  • NC_000013.11:g.20189031C>T
  • NG_008358.1:g.8945G>A
  • NM_004004.6:c.551G>AMANE SELECT
  • NP_003995.2:p.Arg184Gln
  • NP_003995.2:p.Arg184Gln
  • LRG_1350t1:c.551G>A
  • LRG_1350:g.8945G>A
  • LRG_1350p1:p.Arg184Gln
  • NC_000013.10:g.20763170C>T
  • NM_004004.5:c.551G>A
  • P29033:p.Arg184Gln
Protein change:
R184Q; ARG184GLN
Links:
UniProtKB: P29033#VAR_023614; OMIM: 121011.0039; dbSNP: rs80338950
NCBI 1000 Genomes Browser:
rs80338950
Molecular consequence:
  • NM_004004.6:c.551G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Nonsyndromic genetic hearing loss
Synonyms:
Nonsyndromic hearing loss and deafness; Non-syndromic genetic deafness; Nonsyndromic genetic deafness
Identifiers:
MONDO: MONDO:0019497; MedGen: C5680182; Orphanet: 87884

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002572298Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Aug 24, 2022)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link,

SCV004015013Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals
no assertion criteria provided

(ACMG Guidelines, 2015)
Pathogenic
(Mar 31, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.

Hamelmann C, Amedofu GK, Albrecht K, Muntau B, Gelhaus A, Brobby GW, Horstmann RD.

Hum Mutat. 2001;18(1):84-5.

PubMed [citation]
PMID:
11439000

Mutation spectrum of the connexin 26 (GJB2) gene in Taiwanese patients with prelingual deafness.

Hwa HL, Ko TM, Hsu CJ, Huang CH, Chiang YL, Oong JL, Chen CC, Hsu CK.

Genet Med. 2003 May-Jun;5(3):161-5.

PubMed [citation]
PMID:
12792423
See all PubMed Citations (9)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002572298.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

Variant summary: GJB2 c.551G>A (p.Arg184Gln) results in a conservative amino acid change located in the Connexin, N-terminal domain (IPR013092) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 254160 control chromosomes (gnomAD). c.551G>A has been reported in the literature in multiple individuals affected with Autosomal Dominant Non-Syndromic Hearing Loss and the variant segregated with the disease (examples: Hamelmann_2001, Hwa_2003, Putcha_2007, Su_2010 and delaLuzArenas-Sordo_2012). The variant has also been identified in multiple individuals as a de novo occurrence (examples: Huang_2011 and Mahdieh_2010). These data indicate that the variant is very likely to be associated with disease. Experimental evidence evaluating an impact on protein function showed a dominant negative effect on both connexin 26 and connexin 30 (example: Su 2010). Nine submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and all laboratories classified the variant as pathogenic (n=8) and likely pathogenic(n=1). Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals, SCV004015013.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024